Search research articles
Contact Us
Filters
Showing results (411-420 of 627) with videos related to
Page
of 63
Sort By:
Circulation. Cardiovascular Interventions
|
December 17, 2021
Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX
Matthew A Cavender, Robert A Harrington, Gregg W Stone, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
December 8, 2021
Association between TNF Receptors and KIM-1 with Kidney Outcomes in Early-Stage Diabetic Kidney Disease
Simke W Waijer, Taha Sen, Clare Arnott, et al.
American Heart Journal Plus : Cardiology Research and Practice
|
March 29, 2024
Efficacy and safety of cangrelor in patients with peripheral artery disease undergoing percutaneous coronary intervention - Insights from the CHAMPION program
J Antonio Gutierrez, Robert A Harrington, Gregg W Stone, et al.
Journal of the American Heart Association
|
May 23, 2024
Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis
Josephine Harrington, Anne S Hellkamp, Kenneth W Mahaffey, et al.
Journal of the American Heart Association
|
March 26, 2013
Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial
Daniel E Singer, Anne S Hellkamp, Jonathan P Piccini, et al.
Circulation
|
May 11, 1999
Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators
K W Mahaffey, R A Harrington, M L Simoons, et al.
The American Journal of Cardiology
|
June 14, 2005
Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes
Kenneth W Mahaffey, Matthew T Roe, Rakhi Kilaru, et al.
The American Journal of Cardiology
|
November 7, 2009
Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY)
Jason P Linefsky, Min Lin, Karen S Pieper, et al.
Mayo Clinic Proceedings. Digital Health
|
July 17, 2025
Racial and Ethnic Representation and Study Engagement in a Siteless Digital Clinical Trial Using a Smartwatch: Findings From the Apple Heart Study
Kaylin T Nguyen, Jingzhi Yu, Haley Hedlin, et al.
Circulation. Cardiovascular Quality and Outcomes
|
June 14, 2013
Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry
Michael W Cullen, Sunghee Kim, Jonathan P Piccini, et al.
Page
of 63
Search research articles
Search
Showing results (411-420 of 627) with videos related to
Sort By:
Page
of 63
Circulation. Cardiovascular Interventions
|
December 17, 2021
Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX
Matthew A Cavender, Robert A Harrington, Gregg W Stone, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
December 8, 2021
Association between TNF Receptors and KIM-1 with Kidney Outcomes in Early-Stage Diabetic Kidney Disease
Simke W Waijer, Taha Sen, Clare Arnott, et al.
American Heart Journal Plus : Cardiology Research and Practice
|
March 29, 2024
Efficacy and safety of cangrelor in patients with peripheral artery disease undergoing percutaneous coronary intervention - Insights from the CHAMPION program
J Antonio Gutierrez, Robert A Harrington, Gregg W Stone, et al.
Journal of the American Heart Association
|
May 23, 2024
Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis
Josephine Harrington, Anne S Hellkamp, Kenneth W Mahaffey, et al.
Journal of the American Heart Association
|
March 26, 2013
Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial
Daniel E Singer, Anne S Hellkamp, Jonathan P Piccini, et al.
Circulation
|
May 11, 1999
Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators
K W Mahaffey, R A Harrington, M L Simoons, et al.
The American Journal of Cardiology
|
June 14, 2005
Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes
Kenneth W Mahaffey, Matthew T Roe, Rakhi Kilaru, et al.
The American Journal of Cardiology
|
November 7, 2009
Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY)
Jason P Linefsky, Min Lin, Karen S Pieper, et al.
Mayo Clinic Proceedings. Digital Health
|
July 17, 2025
Racial and Ethnic Representation and Study Engagement in a Siteless Digital Clinical Trial Using a Smartwatch: Findings From the Apple Heart Study
Kaylin T Nguyen, Jingzhi Yu, Haley Hedlin, et al.
Circulation. Cardiovascular Quality and Outcomes
|
June 14, 2013
Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry
Michael W Cullen, Sunghee Kim, Jonathan P Piccini, et al.
Page
of 63